Cargando…
Vitamin D as a Potential Player in Immunologic Control over Multiple Myeloma Cells: Implications for Adjuvant Therapies
Multiple myeloma (MM) is a plasma cell malignancy with multifactorial etiology. One of the underlying mechanisms is immune system dysregulation. Immunotherapy is being widely introduced into various MM treatment protocols. Nevertheless, little is known about boosting the immune system with supportiv...
Autores principales: | Kulig, Piotr, Łuczkowska, Karolina, Bielikowicz, Anna, Zdrojewska, Debora, Baumert, Bartłomiej, Machaliński, Bogusław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105067/ https://www.ncbi.nlm.nih.gov/pubmed/35565770 http://dx.doi.org/10.3390/nu14091802 |
Ejemplares similares
-
The Evidence That 25(OH)D3 and VK2 MK-7 Vitamins Influence the Proliferative Potential and Gene Expression Profiles of Multiple Myeloma Cells and the Development of Resistance to Bortezomib
por: Łuczkowska, Karolina, et al.
Publicado: (2022) -
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development
por: Łuczkowska, Karolina, et al.
Publicado: (2022) -
Safety of Cryopreserved Stem Cell Infusion through a Peripherally Inserted Central Venous Catheter
por: Milczarek, Sławomir, et al.
Publicado: (2023) -
Lenalidomide in Multiple Myeloma: Review of Resistance Mechanisms, Current Treatment Strategies and Future Perspectives
por: Kulig, Piotr, et al.
Publicado: (2023) -
The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma
por: Łuczkowska, Karolina, et al.
Publicado: (2021)